SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| ZELIRA THERAPEUTICS LIMITED | 05/12/2019 | |
| ZELDA THERAPEUTICS LIMITED | 11/10/2016 | 05/12/2019 |
| GLENEAGLE GOLD LIMITED | 11/10/2016 |
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)The company reports Mr. Tim Slate has secured a AUD$50,000 working capital Loan Note viewed favorably by the Board. It may convert to a Convertible Loan Note, pending shareholder approval, with a conversion price of AUD$0.58, featuring premiums over recent prices. | 10/03/2026 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 2 March 2026, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 27 February 2026, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 02/03/2026 |
name changed from Zelda Therapeutics Limited | 05/12/2019 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Osagie Imasogie | Chairman | 02/12/2019 |
| Oludare Odumosu | Managing Director | 02/12/2019 |
| Donna O'Donnell | Non Exec Director | 01/06/2023 |
| Tim Slate | Non Exec Director, Company Secretary | 31/01/2022 |
| Greg Blake | Executive Director | 20/02/2023 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
